{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:52:20Z","timestamp":1790175140080,"version":"4.1.0"},"reference-count":42,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2018,8,17]]},"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Progressive encephalopathy, hypsarrhythmia and optic atrophy (PEHO) has been described as a clinically distinct syndrome. It has been postulated that it is an autosomal recessive condition. However, the aetiology is poorly understood, and the genetic basis of the condition has not been fully elucidated. Our objective was to discover if PEHO syndrome is a single gene disorder.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Children with PEHO and PEHO-like syndrome were recruited. Clinical, neurological and dysmorphic features were recorded; EEG reports and MRI scans were reviewed. Where possible, exome sequencing was carried out first to seek mutations in known early infantile developmental and epileptic encephalopathy (DEE) genes and then to use an agnostic approach to seek novel candidate genes. We sought intra\u2013interfamilial phenotypic correlations and genotype\u2013phenotype correlations when pathological mutations were identified.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-three children were recruited from a diverse ethnic background, 19 of which were suitable for inclusion. They were similar in many of the core and the supporting features of PEHO, but there was significant variation in MRI and ophthalmological findings, even between siblings with the same mutation. A pathogenic genetic variant was identified in 15 of the 19 children. One further girl\u2019s DNA failed analysis, but her two affected sisters shared confirmed variants. Pathogenic variants were identified in seven different genes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We found significant clinical and genetic heterogeneity. Given the intrafamily variation demonstrated, we question whether the diagnostic criteria for MRI and ophthalmic findings should be altered. We also question whether PEHO and PEHO-like syndrome represent differing points on a clinical spectrum of the DEE. We conclude that PEHO and PEHO-like syndrome are clinically and genetically diverse entities\u2014and are phenotypic endpoints of many severe genetic encephalopathies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2018-105288","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T12:15:57Z","timestamp":1538655357000},"page":"803-813","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["PEHO syndrome: the endpoint of different genetic epilepsies"],"prefix":"10.1136","volume":"55","author":[{"given":"Manali","family":"Chitre","sequence":"first","affiliation":[{"name":"Department of Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Nahorski","sequence":"additional","affiliation":[{"name":"Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Stouffer","sequence":"additional","affiliation":[{"name":"Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryony","family":"Dunning-Davies","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamish","family":"Houston","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Wakeling","sequence":"additional","affiliation":[{"name":"North West Thames Regional Genetics Service, London North West Healthcare NHS Trust, Harrow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela F","family":"Brady","sequence":"additional","affiliation":[{"name":"North West Thames Regional Genetics Service, London North West Healthcare NHS Trust, Harrow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer M","family":"Zuberi","sequence":"additional","affiliation":[{"name":"Paediatric Neurosciences Research Group, Royal Hospital for Children & University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohnish","family":"Suri","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair P J","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-2101","authenticated-orcid":false,"given":"C Geoffrey","family":"Woods","sequence":"additional","affiliation":[{"name":"Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"key":"2025100520565033000_55.12.803.1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1399-0004.1991.tb03027.x","article-title":"Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome)","volume":"39","author":"Salonen","year":"1991","journal-title":"Clin Genet"},{"key":"2025100520565033000_55.12.803.2","first-page":"241","article-title":"Infantile cerebello-optic atrophy. Neuropathology of the progressive encephalopathy syndrome with edema, hypsarrhythmia and optic atrophy (the PEHO syndrome)","volume":"85","author":"Haltia","year":"1993","journal-title":"Acta Neuropathol"},{"key":"2025100520565033000_55.12.803.3","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.30.11.932"},{"key":"2025100520565033000_55.12.803.4","first-page":"861","article-title":"PEHO syndrome (progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy): neuroradiologic findings","volume":"14","author":"Somer","year":"1993","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025100520565033000_55.12.803.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb00453.x"},{"key":"2025100520565033000_55.12.803.6","doi-asserted-by":"publisher","DOI":"10.1097\/00019605-199604000-00006"},{"key":"2025100520565033000_55.12.803.7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajmg.a.20216","article-title":"PEHO and PEHO-like syndromes: report of five Australian cases","volume":"122A","author":"Field","year":"2003","journal-title":"Am J Med Genet A"},{"key":"2025100520565033000_55.12.803.8","first-page":"1","article-title":"Progressive encephalopathy with oedema, hypsarrhythmia and optic atrophy (PEHO syndrome): report of the first Italian cases","volume":"1","author":"Salpietro","year":"2013","journal-title":"Child A J Pediatr"},{"key":"2025100520565033000_55.12.803.9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2007-979771","article-title":"Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome) in two Japanese siblings","volume":"26","author":"Fujimoto","year":"1995","journal-title":"Neuropediatrics"},{"key":"2025100520565033000_55.12.803.10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32371"},{"key":"2025100520565033000_55.12.803.11","doi-asserted-by":"publisher","DOI":"10.1097\/00019605-200304000-00012"},{"key":"2025100520565033000_55.12.803.12","first-page":"1044","article-title":"[Progressive encephalopathy with oedema, hypsarrhythmia and optic atrophy (PEHO syndrome). A case report]","volume":"36","author":"Nieto-Barrera","year":"2003","journal-title":"Rev Neurol"},{"key":"2025100520565033000_55.12.803.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2004.08.006"},{"key":"2025100520565033000_55.12.803.14","doi-asserted-by":"publisher","DOI":"10.1177\/08830738050200051801"},{"key":"2025100520565033000_55.12.803.15","doi-asserted-by":"publisher","DOI":"10.1177\/0883073810396582"},{"key":"2025100520565033000_55.12.803.16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0887-8994(94)90470-7","article-title":"PEHO syndrome in 3 non-finnish patients","volume":"11","author":"Caraballo","year":"1994","journal-title":"Pediatr Neurol"},{"key":"2025100520565033000_55.12.803.17","first-page":"1555","article-title":"Serial MR imaging, diffusion tensor imaging, and MR spectroscopic findings in a child with progressive encephalopathy, edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome","volume":"27","author":"Huisman","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025100520565033000_55.12.803.18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neurad.2007.06.003","article-title":"Serial MRI in a child with PEHO syndrome","volume":"34","author":"Sonmez","year":"2007","journal-title":"J Neuroradiol"},{"key":"2025100520565033000_55.12.803.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02051.x"},{"key":"2025100520565033000_55.12.803.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00231.x"},{"key":"2025100520565033000_55.12.803.21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ejhg.2015.217","article-title":"De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome","volume":"24","author":"Langlois","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"2025100520565033000_55.12.803.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2016.03.011"},{"key":"2025100520565033000_55.12.803.23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv149"},{"key":"2025100520565033000_55.12.803.24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-017-4325-y","article-title":"Functional SNP allele discovery (fSNPd): an approach to find highly penetrant, environmental-triggered genotypes underlying complex human phenotypes","volume":"18","author":"Stouffer","year":"2017","journal-title":"BMC Genomics"},{"key":"2025100520565033000_55.12.803.25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam9243"},{"key":"2025100520565033000_55.12.803.26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajhg.2017.03.008","article-title":"PLAA mutations cause a lethal infantile epileptic encephalopathy by disrupting ubiquitin-mediated endolysosomal degradation of synaptic proteins","volume":"100","author":"Hall","year":"2017","journal-title":"Am J Hum Genet"},{"key":"2025100520565033000_55.12.803.27","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/ajmg.a.33531","article-title":"Pontocerebellar hypoplasia type 6: a British case with PEHO-like features","volume":"152A","author":"Rankin","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2025100520565033000_55.12.803.28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.neuron.2015.09.048","article-title":"Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease","volume":"88","author":"Karaca","year":"2015","journal-title":"Neuron"},{"key":"2025100520565033000_55.12.803.29","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/brain\/awx155","article-title":"The phenotypic and molecular spectrum of PEHO syndrome and PEHO-like disorders","volume":"140","author":"Salpietro","year":"2017","journal-title":"Brain"},{"key":"2025100520565033000_55.12.803.30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/brain\/awx014","article-title":"PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment","volume":"140","author":"Zollo","year":"2017","journal-title":"Brain"},{"key":"2025100520565033000_55.12.803.31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww014"},{"key":"2025100520565033000_55.12.803.32","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2025100520565033000_55.12.803.33","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000068548.58498.41"},{"key":"2025100520565033000_55.12.803.34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001523"},{"key":"2025100520565033000_55.12.803.35","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.celrep.2016.08.067","article-title":"Trans-Binding Mechanism of Ubiquitin-like Protein Activation Revealed by a UBA5-UFM1 Complex","volume":"16","author":"Oweis","year":"2016","journal-title":"Cell Rep"},{"key":"2025100520565033000_55.12.803.36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajhg.2016.06.020","article-title":"Biallelic variants in UBA5 link dysfunctional UFM1\u00a0ubiquitin-like modifier pathway to severe infantile-onset encephalopathy","volume":"99","author":"Muona","year":"2016","journal-title":"Am J Hum Genet"},{"key":"2025100520565033000_55.12.803.37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajhg.2016.06.030","article-title":"Biallelic Variants in UBA5 Reveal that Disruption of the UFM1 Cascade Can Result in Early-Onset Encephalopathy","volume":"99","author":"Colin","year":"2016","journal-title":"Am J Hum Genet"},{"key":"2025100520565033000_55.12.803.38","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100218"},{"key":"2025100520565033000_55.12.803.39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036681"},{"key":"2025100520565033000_55.12.803.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.08.122"},{"key":"2025100520565033000_55.12.803.41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/awx040","article-title":"ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss","volume":"140","author":"Anttonen","year":"2017","journal-title":"Brain"},{"key":"2025100520565033000_55.12.803.42","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/brain\/awy135","article-title":"Biallelic UFM1 and UFC1 mutations expand the essential role of ufmylation in brain development","volume":"141","author":"Nahorski","year":"2018","journal-title":"Brain"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2018-105288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T03:57:02Z","timestamp":1759723022000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2018-105288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,11,22]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1136\/jmedgenet-2018-105288"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2018-105288","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]}}}